Works by Rousseau, A. F.

Results: 141
    1

    Latent Classes of Adolescent Trauma Exposure, Posttraumatic Stress Disorder Symptoms, and Substance Use Predict Clinical Diagnoses at 12-Month Follow-Up.

    Published in:
    Chronic Stress, 2025, p. 1, doi. 10.1177/24705470251350144
    By:
    • Leri, John;
    • Cisler, Josh M.;
    • Clark, Shaunna L.;
    • Dodd, Cody G.;
    • Siddiqui, Saman;
    • Taylor, Leslie;
    • Ayala, Alexa;
    • Stewart, Sunita;
    • Richmond, Robyn;
    • Shahidullah, Jeffrey D.;
    • Rousseau, Justin F.;
    • Hettema, John M.;
    • Newport, D. Jeffrey;
    • Wagner, Karen D.;
    • Nemeroff, Charles B.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group.

    Published in:
    1996
    By:
    • Leport, Catherine;
    • Ch⩽ne, Geneviève;
    • Morlat, Philippe;
    • Luft, Benjamin J.;
    • Rousseau, Franck;
    • Pueyo, Sophie;
    • Hafner, Richard;
    • Miro, Jose;
    • Aubertin, Jean;
    • Salamon, Roger;
    • Vildé, Jean-Louis;
    • Leport, C;
    • Chêne, G;
    • Morlat, P;
    • Luft, B J;
    • Rousseau, F;
    • Pueyo, S;
    • Hafner, R;
    • Miro, J;
    • Aubertin, J
    Publication type:
    journal article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Increased plasma myostatin in heart failure.

    Published in:
    European Journal of Heart Failure, 2011, v. 13, n. 7, p. 734, doi. 10.1093/eurjhf/hfr024
    By:
    • Gruson, Damien;
    • Ahn, Sylvie A.;
    • Ketelslegers, Jean-Marie;
    • Rousseau, Michel F.
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility.

    Published in:
    CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 8, p. 804, doi. 10.1002/psp4.12669
    By:
    • Musuamba, Flora T.;
    • Skottheim Rusten, Ine;
    • Lesage, Raphaëlle;
    • Russo, Giulia;
    • Bursi, Roberta;
    • Emili, Luca;
    • Wangorsch, Gaby;
    • Manolis, Efthymios;
    • Karlsson, Kristin E.;
    • Kulesza, Alexander;
    • Courcelles, Eulalie;
    • Boissel, Jean‐Pierre;
    • Rousseau, Cécile F.;
    • Voisin, Emmanuelle M.;
    • Alessandrello, Rossana;
    • Curado, Nuno;
    • Dall'ara, Enrico;
    • Rodriguez, Blanca;
    • Pappalardo, Francesco;
    • Geris, Liesbet
    Publication type:
    Article
    41

    Verifying and Validating Quantitative Systems Pharmacology and In Silico Models in Drug Development: Current Needs, Gaps, and Challenges.

    Published in:
    CPT: Pharmacometrics & Systems Pharmacology, 2020, v. 9, n. 4, p. 195, doi. 10.1002/psp4.12504
    By:
    • Musuamba, Flora T.;
    • Bursi, Roberta;
    • Manolis, Efthymios;
    • Karlsson, Kristin;
    • Kulesza, Alexander;
    • Courcelles, Eulalie;
    • Boissel, Jean‐Pierre;
    • Lesage, Raphaëlle;
    • Crozatier, Cécile;
    • Voisin, Emmanuelle M.;
    • Rousseau, Cécile F.;
    • Marchal, Thierry;
    • Alessandrello, Rossana;
    • Geris, Liesbet
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50